TSE significantly relieved pain in cancer pain model mice and raised their pain threshold. TSE seems to play a prominent role in promoting the activity of TILs (CD3 + and CD8 + T cells). This immune-cell-derived peripheral analgesic pathway might have widespread potential for clinical use.